According to an article just published in the journal Prostate Cancer and Prostatic Diseases, any effect of taking pomegranate extract in delaying prostate cancer progression over time after first-line treatment may be limited. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: doubling time, extract, juice, pmogranate, PSA | 3 Comments »
It is not exactly “new” news that PSA doubling times calculated using low levels of ultrasensitive PSA data can be very different to those calulated using standard PSA values. However, a new paper has provided some additional data on this issue. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: doubling time, PSA, standard, ultasensitive | 3 Comments »
An article just published on-line in Cancer has demonstrated that, in a cohort of men with a median follow-up of > 10 years, salvage radiation therapy (after first-line radical prostatectomy) reduces all-cause mortality in men with short (< 6 months) and longer (≥ 6 months) PSA doubling times at the time of initial biochemical disease progression. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: doubling time, PSA, PSADT, radiation therapy, radical prostatectomy, salvage | Comments Off on Post-surgical salvage radiation therapy and all-cause patient mortality
Researchers at Johns Hopkins have attempted to correlate data on PSA doubling time (PSADT) with data on prostate cancer progression in men being treated with intermittent androgen deprivation therapy (IADT) after biochemical recurrence of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: androgen deprivation therapy, doubling time, IADT, intermittent, PSA, PSADT | 1 Comment »
It appears that regular use of commercially available pomegranate extract really does have a significant impact on PSA doubling time (PSADT) among men with a rising PSA but no indication of bone metastasis. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: doubling time, extract, pomegranate, progression, PSA, PSADT | 2 Comments »
Earlier studies based on data from Johns Hopkins and the Center for Prostate Disease Research have shown that PSA doubling times are strongly associated with risk for metastasis, prostate cancer-specific, and overall mortality. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: doubling time, prognosis, PSA, PSADT, risk | 3 Comments »
The role of PSA kinetics (i.e., PSA doubling time and PSA velocity) in the early diagnosis of prostate cancer and in the monitoring of patients on active surveillance protocols has been controversial. We now have some more definitive data. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: active surveillance, doubling time, kinetics, PSA, PSADT, PSAV, velocity | 6 Comments »
Over the years there has been a lot of discussion, but few hard facts, about the impact of soy consumption on PSA levels in men with progressive prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: doubling time, isoflavones, PSA, soy milk | 2 Comments »
We have commented several times on the continuing controversy between two research groups on this key topic. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: doubling time, dynamics, outcome, predict, PSA, risk, velocity | 4 Comments »
Today’s news includes information on:
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: docetaxel, doubling time, gabapentin, gefitinib, HIFU, hot flashes, PSA velocity | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 